Abstract
We explored the biochemical basis for the disorder pseudohypophosphatasia (PsHYPT) in one patient by examining the substrate specificity and localization of alkaline phosphatase (ALP) in cultured dermal fibroblasts. Despite substantial ALP activity, in cell homogenates, toward the artificial substrate 4-methyl-umbelliferyl phosphate (4-MUP), there was a marked deficiency in ALP activity toward the natural substrates pyridoxal 5'-phosphate (PLP) and phosphoethanolamine (PEA), indicating altered substrate specificity. Furthermore, although 4-MUP phosphatase (4-MUP-P'tase) activity was predominantly localized as an ecto-enzyme, the small amount of PLP phosphatase (PLP-P'tase) activity was intracellular. This differential localization was apparent in intact cells, since (1) brief acidification of the medium at 4 degrees C inactivated a majority of the 4-MUP-P'tase activity but only 15% of the PLP-P'tase activity (in contrast to greater than 85% inactivation of both in homogenates), (2) greater than 70% of the 4-MUP-P'tase activity but only 30% of the PLP-P'tase activity was released by phosphatidylinositol-specific phospholipase C (PI-PLC) digestion, and (3) degradation of extracellular PLP was less than 35% of that of disrupted cells. Both 4-MUP- and PLP-P'tase activities were predominantly in a lipid-anchored form that could be converted to a soluble, lipid-free form by PI-PLC digestion. Our findings suggest that the clinical and biochemical presentation of this PSHPT patient results from the production of two aberrant ALP species. One form of ALP has appropriate ectoorientation but is preferentially deficient in activity toward natural substrates; the other ALP species has appropriate substrate specificity but is sequestered from substrates by its intracellular location.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bayleran J., Hechtman P., Kolodny E., Kaback M. Tay-Sachs disease with hexosaminidase A: characterization of the defective enzyme in two patients. Am J Hum Genet. 1987 Oct;41(4):532–548. [PMC free article] [PubMed] [Google Scholar]
- Chodirker B. N., Evans J. A., Lewis M., Coghlan G., Belcher E., Philipps S., Seargeant L. E., Sus C., Greenberg C. R. Infantile hypophosphatasia--linkage with the RH locus. Genomics. 1987 Nov;1(3):280–282. doi: 10.1016/0888-7543(87)90056-5. [DOI] [PubMed] [Google Scholar]
- Cole D. E., Salisbury S. R., Stinson R. A., Coburn S. P., Ryan L. M., Whyte M. P. Increased serum pyridoxal-5'-phosphate in pseudohypophosphatasia. N Engl J Med. 1986 Apr 10;314(15):992–993. doi: 10.1056/NEJM198604103141515. [DOI] [PubMed] [Google Scholar]
- Fallon M. D., Teitelbaum S. L., Weinstein R. S., Goldfischer S., Brown D. M., Whyte M. P. Hypophosphatasia: clinicopathologic comparison of the infantile, childhood, and adult forms. Medicine (Baltimore) 1984 Jan;63(1):12–24. [PubMed] [Google Scholar]
- Fedde K. N., Lane C. C., Whyte M. P. Alkaline phosphatase is an ectoenzyme that acts on micromolar concentrations of natural substrates at physiologic pH in human osteosarcoma (SAOS-2) cells. Arch Biochem Biophys. 1988 Aug 1;264(2):400–409. doi: 10.1016/0003-9861(88)90305-0. [DOI] [PubMed] [Google Scholar]
- Fedde K. N., Whyte M. P. Alkaline phosphatase (tissue-nonspecific isoenzyme) is a phosphoethanolamine and pyridoxal-5'-phosphate ectophosphatase: normal and hypophosphatasia fibroblast study. Am J Hum Genet. 1990 Nov;47(5):767–775. [PMC free article] [PubMed] [Google Scholar]
- Macfarlane J. D., Poorthuis B. J., van de Kamp J. J., Russell R. G., Caswell A. M. Hypophosphatasia: biochemical screening of a Dutch kindred and evidence that urinary excretion of inorganic pyrophosphate is a marker for the disease. Clin Chem. 1988 Sep;34(9):1937–1941. [PubMed] [Google Scholar]
- Scriver C. R., Cameron D. Pseudohypophosphatasia. N Engl J Med. 1969 Sep 11;281(11):604–606. doi: 10.1056/NEJM196909112811107. [DOI] [PubMed] [Google Scholar]
- Varki A. P., Reitman M. L., Kornfeld S. Identification of a variant of mucolipidosis III (pseudo-Hurler polydystrophy): a catalytically active N-acetylglucosaminylphosphotransferase that fails to phosphorylate lysosomal enzymes. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7773–7777. doi: 10.1073/pnas.78.12.7773. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weiss M. J., Cole D. E., Ray K., Whyte M. P., Lafferty M. A., Mulivor R. A., Harris H. A missense mutation in the human liver/bone/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7666–7669. doi: 10.1073/pnas.85.20.7666. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Whyte M. P., Mahuren J. D., Fedde K. N., Cole F. S., McCabe E. R., Coburn S. P. Perinatal hypophosphatasia: tissue levels of vitamin B6 are unremarkable despite markedly increased circulating concentrations of pyridoxal-5'-phosphate. Evidence for an ectoenzyme role for tissue-nonspecific alkaline phosphatase. J Clin Invest. 1988 Apr;81(4):1234–1239. doi: 10.1172/JCI113440. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Whyte M. P., Mahuren J. D., Vrabel L. A., Coburn S. P. Markedly increased circulating pyridoxal-5'-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism. J Clin Invest. 1985 Aug;76(2):752–756. doi: 10.1172/JCI112031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Whyte M. P., Vrabel L. A., Schwartz T. D. Adult hypophosphatasia: generalized deficiency of alkaline phosphatase activity demonstrated with cultured skin fibroblasts. Trans Assoc Am Physicians. 1982;95:253–263. [PubMed] [Google Scholar]